Study overview: Researchers from Alliance Medical (Europe) analyzed oncologic PET-CT scans in patients receiving GLP-1 therapy and observed abnormal fluorodeoxyglucose (FDG) uptake patterns that could easily be mistaken for pathological hot spots. In some cases, what appears to be malignant metabolic activity may, in fact, represent drug-induced metabolic redistributionlikely linked to delayed gastric emptying and altered glucose metabolism caused by GLP-1 agonism
Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials Endocrinol Diabetes Metab
Equilbrio da inflamao: Ao regular o estado redox das clulas, ajuda a manter uma resposta inflamatria equilibrada, o que um ponto-chave de venda para formulaes modernas de suporte imunolgico
This transformative oil, infused with L-ascorbic and ferulic acid, prevents fine lines and wrinkles while protecting your skin from free radicals
For individuals interested in the potential benefits associated with these peptides such as weight loss, improved body composition, or enhanced recovery there are safer, evidence-based alternatives available through NHS and private healthcare pathways
All participants were projected to return to their baseline weight 1.7 years after stopping any weight-loss medication, by 1.6 years with the incretin mimetics, and by 1.5 years after stopping semaglutide or tirzepatide